How do you compete against a MedTech Goliath and maintain price integrity? We’re paying another visit to the archives this week so more industry underdogs can hear Trent Campbell’s killer advice.
Prior to his role as VP for Axonic Modulation Technologies, Trent logged a decade of experience in numerous National and Corporate Accounts roles with medical device companies including Atrium Medical (acquired by Maquet/Getinge), Applied Medical, and Fisher & Paykel Healthcare.
Trent knows that while status quo may be your competitor’s greatest weapon—it’s also their biggest weakness. In this popular episode, he shares how new challengers with a disruptive technology can turn the tide by having a brave “clinical champion” in their corner and win with a focus on long-term value. If you’ve been searching for a strategy to reshape demand and avoid commoditization, this episode is for you!
Resources and links from the show: